雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Drugs for Genetic Myopathy Yasushi Oya 1 1Department of Neurology, National Center of Neurology and Psychiatry Keyword: 酵素補充療法 , エクソンスキッピング療法 , 副腎皮質ステロイド , enzyme replacement therapy , exon skipping therapy , corticosteroid pp.517-521
Published Date 2023/5/1
DOI https://doi.org/10.11477/mf.1416202370
  • Abstract
  • Look Inside
  • Reference

Abstract

Specific therapy for genetic myopathy is still limited to enzyme replacement therapy for Pompe disease with alglucosidase alfa and avalglucosidase alfa, and exon skipping therapy with antisense nucleotide viltolarsen for about 7% of patients with Duchenne muscular dystrophy. Corticosteroid treatment (predonisolone 10-15mg/day) to Duchenne muscular dystrophy, from the age of 5-6 years old, regardless of mutations. Continuation of corticosteroid after loss of ambulation is controversial. Becker muscular dystrophy patients and manifesting female carriers of DMD mutation may also benefit from corticosteroid, but adverse effects should be avoided. In other types of muscular dystrophy, usefulness of corticosteroid has been reported but may be more limited. Drug therapy should be added on the basis of appropriate evaluation and fundamental symptomatic treatment including rehabilitation, in genetic myopathy.


Copyright © 2023, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有